$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
VITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and Alabama
10:00am, Wednesday, 17'th Apr 2024
CINCINNATI--(BUSINESS WIRE)--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE) announced the completion of the previously announced purchase of a
Chemed (CHE) Up 2.5% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 28'th Mar 2024
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
10:45am, Monday, 18'th Mar 2024
Investors are optimistic about Chemed (CHE) on strong performance across the VITAS and Roto-Rooter segments.
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
10:00am, Thursday, 14'th Mar 2024
Chemed's (CHE) VITAS segment is set to acquire the hospice assets of Covenant Care in Florida and Alabama.
VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama
09:00am, Wednesday, 13'th Mar 2024
CINCINNATI--(BUSINESS WIRE)--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation (“Chemed”) (NYSE: CHE), announced it entered into an agreement on March 12, 2024 to acqui
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
12:00pm, Friday, 08'th Mar 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024,
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 04'th Mar 2024
Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ADUS vs. CHE: Which Stock Is the Better Value Option?
12:46pm, Thursday, 29'th Feb 2024
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the b
Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand
07:41am, Thursday, 29'th Feb 2024
Chemed's (CHE) fourth-quarter 2023 performance reflects an improvement in VITAS' operational metrics.
Chemed Corporation (CHE) Q4 2023 Earnings Call Transcript
01:42pm, Wednesday, 28'th Feb 2024
Chemed Corporation (CHE) Q4 2023 Earnings Call Transcript
Chemed (CHE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
09:01pm, Tuesday, 27'th Feb 2024
The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Chemed (CHE) Tops Q4 Earnings Estimates
08:16pm, Tuesday, 27'th Feb 2024
Chemed (CHE) came out with quarterly earnings of $6.60 per share, beating the Zacks Consensus Estimate of $6.25 per share. This compares to earnings of $5.39 per share a year ago.
Chemed Reports Fourth-Quarter 2023 Results
04:15pm, Tuesday, 27'th Feb 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, t
Chemed Corporation Declares Quarterly Dividend of 40 Cents
12:27pm, Friday, 16'th Feb 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 40-cents per share on the Company's capital stock, paya
Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28
12:00pm, Wednesday, 14'th Feb 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2023, on Tuesday, February 27, 2024, follow
Sign In
Buy CHE